Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers. (Q38262476)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

triple-negative breast cancer

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

Eduardo Díaz-Rubio

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

Miguel de la Hoya

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

Trinidad Caldes

16

object named as

Trinidad Caldés

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

author name string

Jon Zugazagoitia

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

Pedro Pérez-Segura

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

Arancha Manzano

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

Ana Vega

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

Ana Custodio

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

Alex Teulé

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

Beatriz Martínez

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

Rogelio González-Sarmiento

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

Juan Jesús Cruz-Hernández

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

Isabel Chirivella

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

Vicente Garcés

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

Pilar Garre

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

language of work or name

0 references

publication date

24 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

148

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

415-421

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342642 AND SRC:MED&resulttype=core&format=json

21 February 2020

Familial breast cancer

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Inherited susceptibility to common cancers

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family history

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: The Korean Hereditary Breast Cancer (KOHBRA) Study

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Limited family structure and BRCA gene mutation status in single cases of breast cancer

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Triple-Negative Breast Cancer

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Genetic susceptibility to triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

The prevalence of BRCA1 mutations among young women with triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Relative contributions of BRCA1 and BRCA2 mutations to "triple-negative" breast cancer in Ashkenazi Women

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Determining Carrier Probabilities for Breast Cancer–Susceptibility Genes BRCA1 and BRCA2

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPRO

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Simplifying clinical use of the genetic risk prediction model BRCAPRO.

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Assessment of the prevalence of de novo mutations in the BRCA1 and BRCA2 genes

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Breast cancer in young women

1 reference

https://api.crossref.org/works/10.1007/S10549-014-3167-4

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38262476&oldid=2270409261"